Cite this: Treating the Ocular Component of Allergic Rhinoconjunctivitis and Related Eye Disorders - Medscape - Aug 15, 2007. Abstract and Introduction Epidemiology of Ocular Allergy ...

DelveInsight's "Allergic Rhino-Conjunctivitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Allergic Rhino-Conjunctivitis, historical ...

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the start of a pivotal phase 3 trial of its investigational ToleroMune® cat allergy treatment for cat ...

Safety data of long-term 300IR 5-grass sublingual tab showed that he most frequent ADRs were generally mild decreased in incidence over the years.

Jorien B. Wartna, from the Erasmus Medical Center in Rotterdam, Netherlands, and colleagues randomized 150 children (aged 6 to 18 years) with pollen-related allergic rhinoconjunctivitis to receive ...

A 36-year-old female patient presented with allergic rhinoconjunctivitis to pollens, had never had immunotherapy, but had a history of 4 episodes of anaphylaxis to dogs.

Cytos Biotechnology AG: CYT003-QbG10 monotherapy for the treatment of allergic rhinoconjunctivitis is safe and efficacious in phase IIb Cytos Biotechnology AG (CYTN.SW - Nachrichten) / Research ...

Women who have been exposed to domestic violence and abuse are at greater risk for asthma, atopic eczema and allergic rhinoconjunctivitis, according to a study published in The Journal of Allergy ...

Significantly better rhinoconjunctivitis QOL scores (P<0.0001) and patients’ own overall assessment of their health status (visual analogue scale (EQ-VAS], P = 0.0025) were also shown.

Suggested remit - To appraise the clinical and cost effectiveness of SGT320 within its marketing authorisation for treating allergic rhinitis or rhinoconjunctivitis caused by house dust mites. 27 ...

DGAP-News: Cytos Biotechnology AG: CYT003-QbG10 monotherapy for the treatment of allergic rhinoconjunctivitis is safe and efficacious in phase IIb study Cytos Biotechnology AG / Research Update.